Identification of CNS Injury-Related microRNAs as Novel Toll-Like Receptor 7/8 Signaling Activators by Small RNA Sequencing.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
11 01 2020
Historique:
received: 03 12 2019
revised: 06 01 2020
accepted: 07 01 2020
entrez: 17 1 2020
pubmed: 17 1 2020
medline: 11 3 2021
Statut: epublish

Résumé

Toll-like receptors (TLRs) belong to pattern recognition receptors, which respond to danger signals such as pathogen-associated molecular patterns or damage-associated molecular patterns. Upon TLR activation in microglia, the major immune cells in the brain, distinct signaling cascades trigger the production of inflammatory molecules, being a critical feature in neuroinflammation and neurodegenerative processes. Recently, individual microRNAs (miRNAs) were shown to act as endogenous TLR ligands. Here, we conducted systematic screening for miRNAs as potential TLR7/8 ligands by small RNA sequencing of apoptotic neurons and their corresponding supernatants. Several miRNA species were identified in both supernatants and injured neurons, and 83.3% of the media-enriched miRNAs activated murine and/or human TLR7/8 expressed in HEK293-derived TLR reporter cells. Among the detected extracellular miRNAs, distinct miRNAs such as miR-340-3p and miR-132-5p induced cytokine and chemokine release from microglia and triggered neurotoxicity in vitro. Taken together, our systematic study establishes miRNAs released from injured neurons as new TLR7/8 activators, which contribute to inflammatory and neurodegenerative responses in the central nervous system (CNS).

Identifiants

pubmed: 31940779
pii: cells9010186
doi: 10.3390/cells9010186
pmc: PMC7017345
pii:
doi:

Substances chimiques

Cytokines 0
MicroRNAs 0
Toll-Like Receptor 7 0
Toll-Like Receptor 8 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Nucleic Acids Res. 2015 Jul 1;43(W1):W460-6
pubmed: 25977294
Mol Cancer. 2014 Feb 21;13:33
pubmed: 24555688
Clin Cancer Res. 2012 Jan 15;18(2):499-509
pubmed: 22128302
J Neurosci. 1998 Oct 15;18(20):8186-97
pubmed: 9763465
Cell Death Differ. 2000 Mar;7(3):250-61
pubmed: 10745270
J Biol Chem. 2006 Dec 8;281(49):37427-34
pubmed: 17040905
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):E2110-6
pubmed: 22753494
Nat Rev Immunol. 2014 Jul;14(7):463-77
pubmed: 24962261
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5598-603
pubmed: 15034168
PLoS One. 2014 Aug 19;9(8):e105421
pubmed: 25136908
Oncotarget. 2015 Apr 20;6(11):9257-70
pubmed: 25831237
Mol Immunol. 2010 Feb;47(5):1083-90
pubmed: 20004021
Exp Neurol. 1995 Oct;135(2):153-9
pubmed: 7589326
ACS Chem Neurosci. 2014 Oct 15;5(10):884-94
pubmed: 25210999
Neuroreport. 2007 Feb 12;18(3):297-300
pubmed: 17314675
Science. 2004 Mar 5;303(5663):1526-9
pubmed: 14976262
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8514-9
pubmed: 12824464
J Immunol. 2017 Sep 15;199(6):2106-2117
pubmed: 28768728
Microrna. 2013;2(1):14-9
pubmed: 25070711
J Immunol. 2012 Aug 1;189(3):1448-58
pubmed: 22745379
Nat Immunol. 2010 May;11(5):373-84
pubmed: 20404851
Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):61-7
pubmed: 11146107
Eur J Immunol. 2003 Nov;33(11):2987-97
pubmed: 14579267
PLoS One. 2018 Jul 16;13(7):e0200602
pubmed: 30011310
Oncogene. 2015 Jun;34(25):3240-50
pubmed: 25151966
Nat Immunol. 2002 Jun;3(6):499
pubmed: 12032557
Brain Res. 2008 Oct 21;1236:185-93
pubmed: 18710654
J Immunol. 2004 Sep 15;173(6):3916-24
pubmed: 15356140
J Cereb Blood Flow Metab. 2013 Dec;33(12):1976-82
pubmed: 24002437
Nat Immunol. 2008 Oct;9(10):1157-64
pubmed: 18758466
J Immunol. 2002 Jan 15;168(2):554-61
pubmed: 11777946
Front Pharmacol. 2017 Oct 25;8:770
pubmed: 29118714
Science. 2004 Mar 5;303(5663):1529-31
pubmed: 14976261
Biomed Res Int. 2017;2017:8030369
pubmed: 29057267
Nat Rev Immunol. 2004 Jul;4(7):499-511
pubmed: 15229469
Glia. 2013 Jul;61(7):1018-28
pubmed: 23650073
PLoS One. 2010 Oct 20;5(10):e13515
pubmed: 20976003
J Immunol. 2008 Mar 15;180(6):3729-38
pubmed: 18322178
Nat Neurosci. 2012 Jun;15(6):827-35
pubmed: 22610069
Curr Top Microbiol Immunol. 2009;336:1-14
pubmed: 19688325
Neurotoxicology. 2018 Jan;64:267-277
pubmed: 28450057
Biochem Biophys Res Commun. 2015 May 8;460(3):670-7
pubmed: 25817794
Neuroscientist. 2018 Jun;24(3):221-245
pubmed: 28737113
J Alzheimers Dis. 2008 May;14(1):27-41
pubmed: 18525125

Auteurs

Thomas Wallach (T)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.

Max Wetzel (M)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.

Paul Dembny (P)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.

Ori Staszewski (O)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Berta-Ottenstein-Programme for Clinician Scientists, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Christina Krüger (C)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.

Alice Buonfiglioli (A)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.

Marco Prinz (M)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79106 Freiburg, Germany.
Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Seija Lehnardt (S)

Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.
Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH